Latest / Driving the Business of Science

Pharma Start-ups. Perspectives from a Serial Entrepreneur.
Send us Fan Mail
In this episode of the Driving the Business of Science podcast, hosted by Keith Parent, CEO of Court Square Group, guest Mark Connell, Co-Founder and President of SLBST Pharma, discusses the company’s mission to repurpose hydroxychloroquine to treat endometriosis, a condition affecting 7 million American women. Despite limited current therapies, SLBST Pharma aims to leverage the drug’s proven efficacy in reducing lesions by 60%. Challenges include navigating the complexities of drug development, fundraising, and staying agile amidst setbacks. Connell emphasizes the importance…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.